This inventor holds 3 USPTO granted patents. Top assignees: Pharma Mar, S.a., University of Illinois. Active years: 2001-2006.
Company Filing History:
Years Active: 2001-2006
Title: The Innovations of Joel Reid
Introduction
Joel Reid is an accomplished inventor based in Rochester, MN (US). He has made significant contributions to the field of biochemistry, particularly in the study of ecteinascidin metabolites. With a total of 3 patents to his name, Reid's work has advanced our understanding of drug metabolism and its implications for therapeutic applications.
Latest Patents
Reid's latest patents focus on the metabolites of ecteinascidin 743. He has successfully purified and elucidated the structure of several products resulting from the metabolism of Et 743 by human cytochrome CYP3A4. These compounds are designated as 'ETM' followed by a numeric value representing their approximate molecular weight. To date, three compounds have been identified: ETM 305, ETM 775, and ETM 204. The structures of these ecteinascidin metabolites are crucial for further research and development in pharmacology.
Career Highlights
Throughout his career, Joel Reid has worked with notable organizations such as Pharma Mar, S.A. and the University of Illinois. His expertise in biochemistry and drug metabolism has positioned him as a key figure in his field. Reid's innovative approaches have led to advancements that benefit both scientific research and practical applications in medicine.
Collaborations
Reid has collaborated with esteemed colleagues, including Kenneth L. Rinehart and Jose J. Morales. These partnerships have fostered a collaborative environment that enhances research outcomes and drives innovation in the study of drug metabolism.
Conclusion
Joel Reid's contributions to the field of biochemistry through his patents and collaborations highlight his role as a significant inventor. His work on ecteinascidin metabolites continues to influence research and development in pharmacology.